Trentin L, Ambrosetti A, Zambello R, Agostini C, Masciarelli M, Vinante F, Chilosi M, Pizzolo G, Cetto G, Semenzato G
Padua University School of Medicine, Department of Clinical Medicine, Italy.
Leuk Res. 1987;11(9):843-7. doi: 10.1016/0145-2126(87)90069-5.
To further define the mechanisms responsible for the alpha-interferon (alpha-IFN) efficacy in the treatment of hairy cell leukemia (HCL), experiments were carried out to specify the cytotoxic events taking place following this type of therapy. Although an increased natural killer (NK) activity was demonstrable after alpha-IFN treatment, evidence has been provided that hairy cells were not specifically lysed either by fresh autologous/allogenic NK lymphocytes or by lymphokine activated killer (LAK) cells. This property could not be induced in vitro by alpha-IFN or by interleukin-2 (IL-2). Our data favour the hypothesis that the increase of NK cell activity observed following alpha-IFN therapy has not a direct antineoplastic effect but is likely to be of relevance for a non-specific enhancement of the host immune system. In alpha-IFN treated HCL this latter property may account for the better resistance to infections which usually represents the major cause of mortality in these patients.
为进一步明确α-干扰素(α-IFN)治疗毛细胞白血病(HCL)有效的机制,我们开展了实验以明确此类治疗后发生的细胞毒性事件。尽管α-IFN治疗后可证明自然杀伤(NK)活性增强,但已有证据表明,新鲜的自体/异体NK淋巴细胞或淋巴因子激活的杀伤(LAK)细胞均不能特异性裂解毛细胞。α-IFN或白细胞介素-2(IL-2)在体外均无法诱导此特性。我们的数据支持以下假说:α-IFN治疗后观察到的NK细胞活性增加并无直接抗肿瘤作用,而可能与宿主免疫系统的非特异性增强有关。在接受α-IFN治疗的HCL患者中,后一种特性可能是其对感染具有更好抵抗力的原因,而感染通常是这些患者死亡的主要原因。